How to buy Globus Medical stock (GMED)

Globus Medical is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $82.63 – an increase of 0.25% over the previous week. Globus Medical employs 5,000 staff and has a trailing 12-month revenue of around $2.5 billion.

Our top picks for where to buy Globus Medical stock

Buy Globus Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Globus Medical stock price (NYSE: GMED)

Use our graph to track the performance of GMED stocks over time.

Globus Medical shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$82.63
52-week range	$49.33 - $87.22
50-day moving average more info button	$79.01
200-day moving average more info button	$67.70
Wall St. target price	$94.23
PE ratio more info button	131.9032
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.62

Is it a good time to buy Globus Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Globus Medical price performance over time

Historical closes compared with the close of $81.94 from 2024-12-19

1 week (2024-12-13)	-0.58%
1 month (2024-11-21)	-3.50%
3 months (2024-09-20)	16.00%
6 months (2024-06-21)	23.18%

1 year (2023-12-21)	51.85%
2 years (2022-12-21)	10.95%
3 years (2021-12-21)	16.76%
5 years (2019-12-20)	39.28%

Is Globus Medical stock undervalued or overvalued?

Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Globus Medical's P/E ratio

Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 132x. In other words, Globus Medical shares trade at around 132x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Globus Medical's PEG ratio

Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1707. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Globus Medical's EBITDA

Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $652 million.

The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.

Globus Medical financials

Revenue TTM	$2.5 billion
Operating margin TTM	17.67%
Gross profit TTM	$759.1 million
Return on assets TTM	4.73%
Return on equity TTM	2.22%
Profit margin	3.69%
Book value	$29.94
Market Capitalization more info button	$11.1 billion

TTM: trailing 12 months

Globus Medical share dividends

We're not expecting Globus Medical to pay a dividend over the next 12 months.

Globus Medical share price volatility

Over the last 12 months, Globus Medical's shares have ranged in value from as little as $49.33 up to $87.22. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 1.169. This would suggest that Globus Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Globus Medical overview

Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc.

Frequently asked questions

null
What percentage of Globus Medical is owned by insiders or institutions?
Currently 0.622% of Globus Medical shares are held by insiders and 81.919% by institutions. How many people work for Globus Medical?
Latest data suggests 5,000 work at Globus Medical. When does the fiscal year end for Globus Medical?
Globus Medical's fiscal year ends in December. Where is Globus Medical based?
Globus Medical's address is: 2560 General Armistead Avenue, Audubon, PA, United States, 19403 What is Globus Medical's ISIN number?
Globus Medical's international securities identification number is: US3795772082 What is Globus Medical's CUSIP number?
Globus Medical's Committee on Uniform Securities Identification Procedures number is: 379577208